{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1390019977295906304.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.11405/nisshoshi.121.729"}},{"identifier":{"@type":"PMID","@value":"39261053"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@language":"en","@value":"Recurrence of hepatocellular carcinoma following liver transplantation"},{"@language":"ja","@value":"肝移植後の肝細胞癌再発"}],"dc:language":"ja","description":[{"type":"abstract","notation":[{"@language":"ja","@value":"<p>肝細胞癌に対する肝移植の保険適用は5-5-500基準内もしくはミラノ基準内であり，肝細胞癌治療アルゴリズムではChild-Pugh分類C症例に推奨されている．肝移植は良好な治療成績をあげているが，一定数の再発を認める．術前因子や病理学的因子を用いた再発予測の検討や，ダウンステージの有用性が報告されている．肝移植後再発症例の予後不良因子として移植後早期再発，AFP高値，根治治療不能が報告されており，mTOR阻害剤を用いた免疫抑制剤の調節，可能な場合における積極的外科治療や局所療法の介入，マルチキナーゼ阻害剤を中心とした薬物療法のシークエンス治療が，肝移植後再発の治療において重要となる．</p>"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410019977295906433","@type":"Researcher","foaf:name":[{"@language":"en","@value":"ITOH Shinji"},{"@language":"ja","@value":"伊藤 心二"}],"jpcoar:affiliationName":[{"@language":"ja","@value":"九州大学大学院消化器・総合外科"},{"@language":"en","@value":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410019977295906432","@type":"Researcher","foaf:name":[{"@language":"en","@value":"TOSHIMA Takeo"},{"@language":"ja","@value":"戸島 剛男"}],"jpcoar:affiliationName":[{"@language":"ja","@value":"九州大学大学院消化器・総合外科"},{"@language":"en","@value":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410019977295906304","@type":"Researcher","foaf:name":[{"@language":"en","@value":"YOSHIZUMI Tomoharu"},{"@language":"ja","@value":"吉住 朋晴"}],"jpcoar:affiliationName":[{"@language":"ja","@value":"九州大学大学院消化器・総合外科"},{"@language":"en","@value":"Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"04466586"},{"@type":"EISSN","@value":"13497693"}],"prism:publicationName":[{"@language":"en","@value":"Nippon Shokakibyo Gakkai Zasshi"},{"@language":"ja","@value":"日本消化器病学会雑誌"},{"@language":"en","@value":"Nippon Shokakibyo Gakkai zasshi"},{"@language":"ja","@value":"日消誌"},{"@language":"en","@value":"Nippon Shokakibyo Gakkai Zasshi"},{"@language":"ja","@value":"日本消化器病学会雑誌"}],"dc:publisher":[{"@language":"en","@value":"The Japanese Society of Gastroenterology"},{"@language":"ja","@value":"一般財団法人 日本消化器病学会"}],"prism:publicationDate":"2024-09-10","prism:volume":"121","prism:number":"9","prism:startingPage":"729","prism:endingPage":"736"},"availableAt":"2024-09-10","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=%E8%82%9D%E7%A7%BB%E6%A4%8D","dc:title":"肝移植"},{"@id":"https://cir.nii.ac.jp/all?q=%E8%82%9D%E7%B4%B0%E8%83%9E%E7%99%8C","dc:title":"肝細胞癌"},{"@id":"https://cir.nii.ac.jp/all?q=%E5%86%8D%E7%99%BA","dc:title":"再発"}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2013355818"},{"@type":"PUBMED","@value":"39261053"}]}